ASX - Delayed Quote AUD

Microba Life Sciences Limited (MAP.AX)

0.1800 +0.0200 (+12.50%)
At close: April 26 at 3:53 PM GMT+10
Currency in AUD All numbers in thousands
Download
Breakdown
TTM
6/30/2023
6/30/2022
Total Revenue
5,420.1360
5,420.1360
4,688.6450
Cost of Revenue
2,741.8730
2,741.8730
2,322.9300
Gross Profit
2,678.2630
2,678.2630
2,365.7150
Operating Expense
22,908.3870
22,908.3870
18,637.7790
Operating Income
-20,230.1240
-20,230.1240
-16,272.0640
Net Non Operating Interest Income Expense
817.6370
817.6370
-5.7380
Other Income Expense
6,737.9180
6,737.9180
4,816.6030
Pretax Income
-12,674.5690
-12,674.5690
-11,461.1990
Tax Provision
5.6430
5.6430
9.2300
Net Income Common Stockholders
-12,680.2120
-12,680.2120
-11,470.4290
Basic EPS
-0.04
--
-0.05
Diluted EPS
-0.04
--
-0.05
Basic Average Shares
332,990.0810
--
236,374.9530
Diluted Average Shares
332,990.0810
--
236,374.9530
Net Income from Continuing & Discontinued Operation
-12,680.2120
-12,680.2120
-11,470.4290
Normalized Income
-12,680.2120
-12,680.2120
-11,470.4290
Interest Income
878.0490
878.0490
49.5510
Interest Expense
16.4090
16.4090
8.3070
Net Interest Income
817.6370
817.6370
-5.7380
EBIT
-12,658.1600
-12,658.1600
-11,452.8920
EBITDA
-11,016.3290
-11,016.3290
-9,910.0300
Reconciled Cost of Revenue
2,741.8730
2,741.8730
2,322.9300
Reconciled Depreciation
1,641.8310
1,641.8310
1,542.8620
Net Income from Continuing Operation Net Minority Interest
-12,680.2120
-12,680.2120
-11,470.4290
Normalized EBITDA
-11,016.3290
-11,016.3290
-9,910.0300
Tax Rate for Calcs
0.0003
0.0003
0.0003
6/30/2022 - 4/5/2022

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers